Amgen Inc.
NASDAQ:AMGN · NASDAQ Global Select
-$6.93 today
Vol 8.12M · Avg 2.76M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+27.64%
Period High
$385.25
Period Low
$264.49
Latest
$337.60
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Merck & Co., Inc.
NYSE:MRK
$281.73B
Novartis AG
NYSE:NVS
$281.18B
Novo Nordisk A/S
NYSE:NVO
$191.28B
Gilead Sciences, Inc.
NASDAQ:GILD
$152.54B
Pfizer Inc.
NYSE:PFE
$143.68B
Danaher Corporation
NYSE:DHR
$125.44B
Bristol-Myers Squibb Company
NYSE:BMY
$109.95B
GSK plc
NYSE:GSK
$101.90B
Sanofi
NASDAQ:SNY
$101.56B
Boston Scientific Corporation
NYSE:BSX
$67.42B
What is the latest AMGN filing?
The latest filing shown is 11-K dated Jun 11, 2026.
How many recent filings does AMGN have?
Intrinsic Alpha currently shows 20 recent filings for AMGN.
Explore More
Continue the stock analysis
Jump to another research area for this company.